2 recruiting, 2 unknown, 1 completed, 1 not yet recruiting. 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Yan Li: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension Perirenal adipose tissue modification by focused power ultrasound, Sham - Resistant Hypertension | Phase 3 | Not yet recruiting | Yan Li | 220 | 2025-11-20 | 2025-11-18 |
| Morning Versus Bedtime Dosing of Antihypertensive Medication Alisartan, Amlodipine besylate - Hypertension, Blood Pressure | Phase 4 | Recruiting | Yan Li | 300 | 2021-01-28 | 2025-01-06 |
| A Prospective Study on The"Management of Hypertension in Young and Middle-aged Subjects in Enterprises Setting" Hypertension, Blood Pressure | Suspended | Yan Li | 2000 | 2019-12-30 | 2025-01-09 | |
| A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients" Hypertension, Blood Pressure | Recruiting | Yan Li | 10000 | 2018-07-18 | 2025-01-06 | |
| Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer Apatinib, SBRT - Breast Cancer | Phase 2 | Unknown | Yan Li | 30 | 2018-03-15 | 2018-03-07 |
| Antihypertensive Treatment in Masked Hypertension Allisartan Isoproxil, Placebo - Masked Hypertension | Phase 4 | Completed | Yan Li | 320 | 2017-02-14 | 2025-01-06 |
| The Study of Blood Pressure Variability to Impact Arterial Stiffness and Carotid Atherosclerosis Carotid Atherosclerosis | Unknown | Yan Li | 1235 | 2012-01-01 | 2011-11-09 |
Hypertension (3) · Breast Neoplasms (1) · Cardiovascular Diseases (1) · Carotid Artery Diseases (1) · Hypertrophy, Left Ventricular (1) · Masked Hypertension (1)
Amlodipine (1) · Radiosurgery (1) · allisartan isoproxil (1) · apatinib (1) · salicylhydroxamic acid (1)
China (5)